Liberate Bio
PrivateLast Round
Seed
Oct 15, 2025
Total Funding Raised
$31M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Liberate Bio is a biotechnology company developing a genetic medicine platform designed to enable targeted delivery of RNA therapies to immune cells beyond the liver.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Liberate Bio Comparables
Compare Liberate Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MOTE Therapeutics | 88% | |
| Mana.bio | 87% | |
| Hopewell Therapeutics | 87% |
Liberate Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 15, 2025 |
Key People
Founding team and executive leadership
Liberate Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 61% MoM.
- Jul 25, 2026
Monthly visitors increased 83% MoM.
Liberate Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Liberate Bio's valuation, stock price, and market status.
Is Liberate Bio a public or private company?
Liberate Bio is a private company.
What is the current stock price of Liberate Bio?
Liberate Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Liberate Bio worth (valuation)?
Valuation information for Liberate Bio is not publicly available.
Can I buy Liberate Bio stock?
Liberate Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Liberate Bio's last funding round?
Liberate Bio's most recent funding round was Seed on October 15, 2025.
Who are the main investors in Liberate Bio?
Key investors in Liberate Bio include Khosla Ventures.
Will Liberate Bio IPO soon?
No public IPO plans have been announced for Liberate Bio.
How can I track Liberate Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Liberate Bio's secondary market activity and sign up for updates.